{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:37:40Z","timestamp":1766504260464},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T00:00:00Z","timestamp":1076544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,4,1]]},"DOI":"10.1038\/sj.leu.2403263","type":"journal-article","created":{"date-parts":[[2004,2,12]],"date-time":"2004-02-12T11:03:04Z","timestamp":1076583784000},"page":"709-719","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"18","author":[{"given":"M","family":"Br\u00fcggemann","sequence":"first","affiliation":[]},{"given":"V H J","family":"van der Velden","sequence":"additional","affiliation":[]},{"given":"T","family":"Raff","sequence":"additional","affiliation":[]},{"given":"J","family":"Droese","sequence":"additional","affiliation":[]},{"given":"M","family":"Ritgen","sequence":"additional","affiliation":[]},{"given":"C","family":"Pott","sequence":"additional","affiliation":[]},{"given":"A J","family":"Wijkhuijs","sequence":"additional","affiliation":[]},{"given":"N","family":"G\u00f6kbuget","sequence":"additional","affiliation":[]},{"given":"D","family":"Hoelzer","sequence":"additional","affiliation":[]},{"given":"E R","family":"van Wering","sequence":"additional","affiliation":[]},{"given":"J J M","family":"van Dongen","sequence":"additional","affiliation":[]},{"given":"M","family":"Kneba","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,2,12]]},"reference":[{"key":"BF2403263_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10428199809059247","volume":"32","author":"SP Dibenedetto","year":"1998","unstructured":"Dibenedetto SP, Lo NL, Di Cataldo A, Schiliro G . Detection of minimal residual disease: methods and relationship to outcome in T-lineage acute lymphoblastic leukemia. Leukemia Lymphoma 1998; 32: 65\u201375.","journal-title":"Leukemia Lymphoma"},{"key":"BF2403263_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/asheducation-2002.1.162","volume":"2002","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR et al. Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2002; 2002: 162\u2013192.","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"BF2403263_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cave","year":"1998","unstructured":"Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer \u2013 Childhood Leukemia Cooperative Group. N Engl J Med 1998; 339: 591\u2013598.","journal-title":"N Engl J Med"},{"key":"BF2403263_CR4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","volume":"351","author":"E Coustan-Smith","year":"1998","unstructured":"Coustan-Smith E, Behm FG, Sanchez J, Boyett JM, Hancock ML, Raimondi SC et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998; 351: 550\u2013554.","journal-title":"Lancet"},{"key":"BF2403263_CR5","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","volume":"96","author":"E Coustan-Smith","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96: 2691\u20132696.","journal-title":"Blood"},{"key":"BF2403263_CR6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V90.3.1226","volume":"90","author":"SP Dibenedetto","year":"1997","unstructured":"Dibenedetto SP, Lo NL, Mayer SP, Rovera G, Schiliro G . Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia. Blood 1997; 90: 1226\u20131232.","journal-title":"Blood"},{"key":"BF2403263_CR7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V78.3.739.739","volume":"78","author":"GA Neale","year":"1991","unstructured":"Neale GA, Menarguez J, Kitchingman GR, Fitzgerald TJ, Koehler M, Mirro Jr J et al. Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood 1991; 78: 739\u2013747.","journal-title":"Blood"},{"key":"BF2403263_CR8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","volume":"352","author":"JJM van Dongen","year":"1998","unstructured":"van Dongen JJM, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731\u20131738.","journal-title":"Lancet"},{"key":"BF2403263_CR9","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood.V99.12.4386","volume":"99","author":"MJ Willemse","year":"2002","unstructured":"Willemse MJ, Seriu T, Hettinger K, d'Aniello E, Hop WC, Panzer-Grumayer ER et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002; 99: 4386\u20134393.","journal-title":"Blood"},{"key":"BF2403263_CR10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","volume":"14","author":"M Bruggemann","year":"2000","unstructured":"Bruggemann M, Droese J, Bolz I, Luth P, Pott C, von Neuhoff N et al. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 2000; 14: 1419\u20131425.","journal-title":"Leukemia"},{"key":"BF2403263_CR11","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood.V95.8.2651","volume":"95","author":"JW Donovan","year":"2000","unstructured":"Donovan JW, Ladetto M, Zou G, Neuberg D, Poor C, Bowers D et al. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia. Blood 2000; 95: 2651\u20132658.","journal-title":"Blood"},{"key":"BF2403263_CR12","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","volume":"12","author":"MJ Pongers-Willemse","year":"1998","unstructured":"Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998; 12: 2006\u20132014.","journal-title":"Leukemia"},{"key":"BF2403263_CR13","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","volume":"16","author":"VHJ van der Velden","year":"2002","unstructured":"van der Velden VHJ, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJM . T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16: 1372\u20131380.","journal-title":"Leukemia"},{"key":"BF2403263_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.leu.2402475","volume":"16","author":"VHJ van der Velden","year":"2002","unstructured":"van der Velden VHJ, Willemse MJ, van der Schoot CE, Hahlen K, van Wering ER, van Dongen JJM . Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928\u2013936.","journal-title":"Leukemia"},{"key":"BF2403263_CR15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VHJ van der Velden","year":"2003","unstructured":"van der Velden VHJ, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJM . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013\u20131034.","journal-title":"Leukemia"},{"key":"BF2403263_CR16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","volume":"14","author":"OJ Verhagen","year":"2000","unstructured":"Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426\u20131435.","journal-title":"Leukemia"},{"key":"BF2403263_CR17","first-page":"1126","volume":"87","author":"P Gameiro","year":"2002","unstructured":"Gameiro P, Mortuza FY, Hoffbrand AV, Foroni L . Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor g and d gene rearrangements. Haematologica 2002; 87: 1126\u20131134.","journal-title":"Haematologica"},{"key":"BF2403263_CR18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0145-2126(01)00130-8","volume":"26","author":"K Nirmala","year":"2002","unstructured":"Nirmala K, Rajalekshmy KR, Raman SG, Shanta V, Rajkumar T . PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease. Leuk Res 2002; 26: 335\u2013343.","journal-title":"Leuk Res"},{"key":"BF2403263_CR19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C Nyvold","year":"2002","unstructured":"Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253\u20131258.","journal-title":"Blood"},{"key":"BF2403263_CR20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.leu.2402636","volume":"16","author":"VHJ van der Velden","year":"2002","unstructured":"van der Velden VHJ, Jacobs C, Wijkhuijs J, Comans-Bitter Willemse J, Hahle K, Kamps A et al. Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia 2002; 16: 1432\u20131436.","journal-title":"Leukemia"},{"key":"BF2403263_CR21","first-page":"183","volume":"87","author":"T Szczepanski","year":"2002","unstructured":"Szczepanski T, van der Velden VHJ, van Dongen JJM . Real-time quantitative (RQ)-PCR for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Haematologica 2002; 87: 183\u2013191.","journal-title":"Haematologica"},{"key":"BF2403263_CR22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1084\/jem.177.4.965","volume":"177","author":"TM Breit","year":"1993","unstructured":"Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig WD, van Wering ER, van Dongen JJM . Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha\/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med 1993; 177: 965\u2013977.","journal-title":"J Exp Med"},{"key":"BF2403263_CR23","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V82.10.3063.3063","volume":"82","author":"TM Breit","year":"1993","unstructured":"Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van Wering ER, van Dongen JJM . Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063\u20133074.","journal-title":"Blood"},{"key":"BF2403263_CR24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.leu.2401071","volume":"12","author":"T Szczepanski","year":"1998","unstructured":"Szczepanski T, Langerak AW, Wolvers-Tettero IL, Ossenkoppele GJ, Verhoef G, Stul M et al. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998; 12: 1081\u20131088.","journal-title":"Leukemia"},{"key":"BF2403263_CR25","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V93.12.4079","volume":"93","author":"TP-WMJ Szczepanski","year":"1999","unstructured":"Szczepanski TP-WMJ, Langerak AW, Harts WA, Wijkhuijs AJM, van Wering ER, van Dongen JJM . Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V\u2013D\u2013J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 1999; 93: 4079\u20134085.","journal-title":"Blood"},{"key":"BF2403263_CR26","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V83.8.2238.2238","volume":"83","author":"A Beishuizen","year":"1994","unstructured":"Beishuizen A, Verhoeven MA, van Wering ER, Hahlen K, Hooijkaas H, van Dongen JJM . Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238\u20132247.","journal-title":"Blood"},{"key":"BF2403263_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/beha.2002.0184","volume":"15","author":"T Szczepanski","year":"2002","unstructured":"Szczepanski T, Flohr T, van der Velden, VHJ, Bartram CR, van Dongen JJM . Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002; 15: 37\u201357.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF2403263_CR28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1038\/sj.leu.2403081","volume":"17","author":"T Szczepanski","year":"2003","unstructured":"Szczepanski T, van der Velden VHJ, Raff T, Jacobs DHJ, van Wering ER, Br\u00fcggemann M et al. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of secondary T-ALL. Leukemia 2003; 17: 2149\u20132156.","journal-title":"Leukemia"},{"key":"BF2403263_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(91)90247-A","volume":"198","author":"JJM van Dongen","year":"1991","unstructured":"van Dongen JJM, Wolvers-Tettero IL . Analysis of immunoglobulin and T cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991; 198: 93\u2013174.","journal-title":"Clin Chim Acta"},{"key":"BF2403263_CR30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2401427","volume":"13","author":"AW Langerak","year":"1999","unstructured":"Langerak AW, Wolvers-Tettero IL, van Dongen JJM . Detection of T cell receptor beta (TCRB) gene rearrangement patterns in T cell malignancies by Southern blot analysis. Leukemia 1999; 13: 965\u2013974.","journal-title":"Leukemia"},{"key":"BF2403263_CR31","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.V96.2.640","volume":"96","author":"C Assaf","year":"2000","unstructured":"Assaf C, Hummel M, Dippel E, Goerdt S, Muller HH, Anagnostopoulos I et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000; 96: 640\u2013646.","journal-title":"Blood"},{"key":"BF2403263_CR32","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood.V86.10.3930.bloodjournal86103930","volume":"86","author":"M Kneba","year":"1995","unstructured":"Kneba M, Bolz I, Linke B, Hiddemann W . Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis. Blood 1995; 86: 3930\u20133937.","journal-title":"Blood"},{"key":"BF2403263_CR33","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.152.10.5109","volume":"152","author":"J Gorski","year":"1994","unstructured":"Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152: 5109\u20135119.","journal-title":"J Immunol"},{"key":"BF2403263_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/eji.1830220237","volume":"22","author":"WM Rosenberg","year":"1992","unstructured":"Rosenberg WM, Moss PA, Bell JI . Variation in human T cell receptor V beta and J beta repertoire: analysis using anchor polymerase chain reaction. Eur J Immunol 1992; 22: 541\u2013549.","journal-title":"Eur J Immunol"},{"key":"BF2403263_CR35","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender L et al. Design and standardization of PCR primers and protocols for detection of immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17: 2257\u20132317.","journal-title":"Leukemia"},{"key":"BF2403263_CR36","first-page":"455","volume":"42","author":"B Arden","year":"1995","unstructured":"Arden B, Clark SP, Kabelitz D, Mak TW . Human T-cell receptor variable gene segment families. Immunogenetics 1995; 42: 455\u2013500.","journal-title":"Immunogenetics"},{"key":"BF2403263_CR37","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.leu.2400887","volume":"11","author":"AW Langerak","year":"1997","unstructured":"Langerak AW, Szczepanski T, van der Burg M, Wolvers-Tettero IL, van Dongen JJM . Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192\u20132199.","journal-title":"Leukemia"},{"key":"BF2403263_CR38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.leu.2400736","volume":"11","author":"B Linke","year":"1997","unstructured":"Linke B, Bolz I, Fayyazi A, von Hofen M, Pott C, Bertram J et al. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia 1997; 11: 1055\u20131062.","journal-title":"Leukemia"},{"key":"BF2403263_CR39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.leu.2402637","volume":"17","author":"MP Lefranc","year":"2003","unstructured":"Lefranc MP . IMGT\u00ae databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis. http:\/\/imgt.cines.fr. Leukemia 2003; 17: 260\u2013266.","journal-title":"Leukemia"},{"key":"BF2403263_CR40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1126\/science.272.5269.1755","volume":"272","author":"L Rowen","year":"1996","unstructured":"Rowen L, Koop BF, Hood L . The complete 685-kilobase DNA sequence of the human beta T cell receptor locus. Science 1996; 272: 1755\u20131762.","journal-title":"Science"},{"key":"BF2403263_CR41","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1182\/blood.V98.8.2456","volume":"98","author":"AW Langerak","year":"2001","unstructured":"Langerak AW, Wolvers-Tettero ILM, Gastel-Mol EJ, Oud MECM, van Dongen JJM . Basic helix\u2013loop\u2013helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood 2001; 98: 2456\u20132465.","journal-title":"Blood"},{"key":"BF2403263_CR42","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1073\/pnas.82.24.8624","volume":"82","author":"B Toyonaga","year":"1985","unstructured":"Toyonaga B et al. Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proc Natl Acad Sci USA 1985; 82: 8624\u20138628.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403263_CR43","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1182\/blood-2002-08-2438","volume":"101","author":"V Asnafi","year":"2003","unstructured":"Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutor P, Estienne MH et al. Analysis of TCR, pTalpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003; 101: 2693\u20132703.","journal-title":"Blood"},{"key":"BF2403263_CR44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0145-2126(00)00025-4","volume":"24","author":"S Sazawal","year":"2000","unstructured":"Sazawal S, Bhatia K, Gurbuxani S, Singh AL, Raina V, Khattar A et al. Pattern. pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India. Leukemia Res 2000; 24: 575\u2013582.","journal-title":"Leukemia Res"},{"key":"BF2403263_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0198-8859(95)00013-T","volume":"43","author":"MA Hall","year":"1995","unstructured":"Hall MA, Lanchbury JS . Healthy human T-cell receptor beta-chain repertoire. Quantitative analysis and evidence for J beta-related effects on CDR3 structure and diversity. Hum Immunol 1995; 43: 207\u2013218.","journal-title":"Hum Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403263","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T23:46:55Z","timestamp":1682639215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,12]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4,1]]}},"alternative-id":["BF2403263"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403263","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,12]]},"assertion":[{"value":"5 September 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}